Intraoperative tumor diagnostics in head and neck tumors using a Raman probe

Not Applicable

Recruiting

• Conditions: Malignant neoplasm of the oral cavity, oropharynx, hypopharynx, larynx; C14.8; C10.8; C32.8; C13.8; J39.1; Overlapping lesion of lip, oral cavity and pharynx; Overlapping lesion of oropharynx; Overlapping lesion of larynx; Overlapping lesion of hypopharynx

• Registration Number: DRKS00028114
• Lead Sponsor: Friedrich-Schiller Universität Jena

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-11-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patient with primary head and neck cancer in the oral cavity, oropharynx, hypopharynx or larynx, tumor size > 5 mm, written consent to participate in the study OR patients with an inflammatory change in the oral cavity, oropharynx, hypopharynx or larynx > 5 mm, written consent to participate in the study

Exclusion Criteria

non

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of the measurement properties in vivo with the ex vivo results; security of the investigation

Secondary Outcome Measures

Name	Time	Method
Development of an algorithm for in vivo investigation; Investigation of the sensitivity and specificity of the Raman examination for the detection of tumor tissue in differentiation from inflammatory tissue and normal tissue